Antibacterial effect of Manuka honey on Clostridium difficile

BMC Research Notes
|May 9, 2013
PubMed
Abstract

Insights

Manuka honey demonstrates bactericidal activity against Clostridium difficile, showing promising potential for treating infections caused by this pathogen. This study confirms Manuka honey

Area of Science:

  • Microbiology
  • Natural Products Chemistry

Background:

  • Manuka honey, derived from the Leptospermum scoparium tree, possesses unique antimicrobial properties attributed to the Unique Manuka Factor.
  • While its antibacterial effects are known against various pathogens, its impact on Clostridium difficile, a significant nosocomial pathogen, remained uninvestigated.

Purpose of the Study:

  • To determine the susceptibility of Clostridium difficile to Manuka honey.
  • To ascertain whether Manuka honey exhibits bactericidal or bacteriostatic activity against C. difficile.

Main Methods:

  • Broth dilution method was employed to establish minimum inhibitory concentrations (MIC) and minimum bactericidal concentrations (MBC) for Manuka honey against three C. difficile strains.
  • Agar well diffusion assay was utilized to assess the sensitivity of C. difficile to varying concentrations of Manuka honey.

Main Results:

  • Manuka honey exhibited consistent MIC and MBC values of 6.25% (v/v) across all three tested C. difficile strains.
  • The antimicrobial action of Manuka honey was confirmed to be bactericidal.
  • A dose-dependent response was observed, with higher Manuka honey concentrations leading to larger zones of inhibition, persisting for over 7 days.

Conclusions:

  • Clostridium difficile displays significant susceptibility to Manuka honey.
  • Manuka honey presents a potential therapeutic option for managing infections caused by Clostridium difficile.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...